Status:
COMPLETED
Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy
Lead Sponsor:
University of North Carolina, Chapel Hill
Conditions:
Joint Pain
Breast Cancer
Eligibility:
FEMALE
21-99 years
Phase:
NA
Brief Summary
For post-menopausal women diagnosed with hormone-receptor positive breast cancer tumors, aromatase inhibitors (AIs) are the standard adjuvant hormone treatment to prolong disease-free survival and tim...
Eligibility Criteria
Inclusion
- Taking an aromatase inhibitor as adjuvant treatment for State I, II, or II breast cancer for at least 4 weeks
- Experiencing more than mild joint pain/symptoms
- 21 or older
- have permission from physician to engage in moderate intensity physical activity
Exclusion
- Undergoing chemotherapy and/or radiation therapy at any time during the study period
- Scheduled for major surgery during the study period
- Presently engaged in high levels of physical activity on a daily basis
- Less than 21 years of age
- Unable to walk or engage in moderate intensity physical activity
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT01900418
Start Date
August 1 2013
End Date
June 1 2016
Last Update
August 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599